Condition

Acute Lymphoblastic Leukemia in Remission

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common interventions14

Lead sponsors shown2

Clinical trials

2 shown

Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and LymphomaNCT07790913 · 2026-10-01

NOT_YET_RECRUITING

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13

COMPLETED

Common interventions

Anti-Thymocyte GlobulinBIOLOGICAL1 BusulfanDRUG1 ClofarabineDRUG1 CyclophosphamideDRUG1 Filgrastim-sndzBIOLOGICAL1 FludarabineDRUG1 Health Behavior and Lifestyle CounselingBEHAVIORAL1 MelphalanDRUG1 Mycophenolate MofetilDRUG1 Phentermine/Topiramate ERDRUG1 RituximabBIOLOGICAL1 TacrolimusDRUG1 Total-Body IrradiationRADIATION1 Umbilical Cord Blood TransplantationPROCEDURE1

Leading sponsors

M.D. Anderson Cancer Center 1 St. Jude Children's Research Hospital 1

Trial status mix

COMPLETED1

NOT_YET_RECRUITING1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.